The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care

Background: Partner notification is the process of providing support for, informing and treating sexual partners of individuals who have been diagnosed with sexually transmitted infections (STIs). It is traditionally undertaken by specialist sexual health services, and may involve informing a partne...

Full description

Bibliographic Details
Main Authors: Jackie A Cassell, Julie Dodds, Claudia Estcourt, Carrie Llewellyn, Stefania Lanza, John Richens, Helen Smith, Merle Symonds, Andrew Copas, Tracy Roberts, Kate Walters, Peter White, Catherine Lowndes, Hema Mistry, Melcior Rossello-Roig, Hilary Smith, Greta Rait
Format: Article
Language:English
Published: NIHR Journals Library 2015-01-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta19050
id doaj-7b18fc5ec25e4f7fa52650014f75f2f1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jackie A Cassell
Julie Dodds
Claudia Estcourt
Carrie Llewellyn
Stefania Lanza
John Richens
Helen Smith
Merle Symonds
Andrew Copas
Tracy Roberts
Kate Walters
Peter White
Catherine Lowndes
Hema Mistry
Melcior Rossello-Roig
Hilary Smith
Greta Rait
spellingShingle Jackie A Cassell
Julie Dodds
Claudia Estcourt
Carrie Llewellyn
Stefania Lanza
John Richens
Helen Smith
Merle Symonds
Andrew Copas
Tracy Roberts
Kate Walters
Peter White
Catherine Lowndes
Hema Mistry
Melcior Rossello-Roig
Hilary Smith
Greta Rait
The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
Health Technology Assessment
author_facet Jackie A Cassell
Julie Dodds
Claudia Estcourt
Carrie Llewellyn
Stefania Lanza
John Richens
Helen Smith
Merle Symonds
Andrew Copas
Tracy Roberts
Kate Walters
Peter White
Catherine Lowndes
Hema Mistry
Melcior Rossello-Roig
Hilary Smith
Greta Rait
author_sort Jackie A Cassell
title The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
title_short The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
title_full The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
title_fullStr The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
title_full_unstemmed The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
title_sort relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
2046-4924
publishDate 2015-01-01
description Background: Partner notification is the process of providing support for, informing and treating sexual partners of individuals who have been diagnosed with sexually transmitted infections (STIs). It is traditionally undertaken by specialist sexual health services, and may involve informing a partner on a patient’s behalf, with consent. With an increasing proportion of STIs diagnosed in general practice and other community settings, there is a growing need to understand the best way to provide partner notification for people diagnosed with a STI in this setting using a web-based referral system. Objective: We aimed to compare three different approaches to partner notification for people diagnosed with chlamydia within general practice. Design: Cluster randomised controlled trial. Setting: General practices in England and, within these, patients tested for and diagnosed with genital chlamydia or other bacterial STIs in that setting using a web-based referral system. Interventions: Three different approaches to partner notification: patient referral alone, or the additional offer of either provider referral or contract referral. Main outcome measures: (1) Number of main partners per index patient treated for chlamydia and/or gonorrhoea/non-specific urethritis/pelvic inflammatory disease; and (2) proportion of index patients testing negative for the relevant STI at 3 months. Results: As testing rates for chlamydia were far lower than expected, we were unable to scale up the trial, which was concluded at pilot stage. We are not able to answer the original research question. We present the results of the work undertaken to improve recruitment to similar studies requiring opportunistic recruitment of young people in general practice. We were unable to standardise provider and contract referral separately; however, we also present results of qualitative work aimed at optimising these interventions. Conclusions: External recruitment may be required to facilitate the recruitment of young people to research in general practice, especially in sensitive areas, because of specific barriers experienced by general practice staff. Costs need to be taken into account together with feasibility considerations. Partner notification interventions for bacterial STIs may not be clearly separable into the three categories of patient, provider and contract referral. Future research is needed to operationalise the approaches of provider and contract partner notification if future trials are to provide generalisable information. Trial registration: Current Controlled Trials ISRCTN24160819. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 5. See the NIHR Journals Library website for further project information.
url https://doi.org/10.3310/hta19050
work_keys_str_mv AT jackieacassell therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT juliedodds therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT claudiaestcourt therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT carriellewellyn therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT stefanialanza therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT johnrichens therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT helensmith therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT merlesymonds therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT andrewcopas therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT tracyroberts therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT katewalters therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT peterwhite therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT catherinelowndes therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT hemamistry therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT melciorrosselloroig therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT hilarysmith therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT gretarait therelativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT jackieacassell relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT juliedodds relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT claudiaestcourt relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT carriellewellyn relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT stefanialanza relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT johnrichens relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT helensmith relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT merlesymonds relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT andrewcopas relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT tracyroberts relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT katewalters relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT peterwhite relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT catherinelowndes relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT hemamistry relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT melciorrosselloroig relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT hilarysmith relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
AT gretarait relativeclinicaleffectivenessandcosteffectivenessofthreecontrastingapproachestopartnernotificationforcurablesexuallytransmittedinfectionsaclusterrandomisedtrialinprimarycare
_version_ 1725813159540817920
spelling doaj-7b18fc5ec25e4f7fa52650014f75f2f12020-11-24T22:09:11ZengNIHR Journals LibraryHealth Technology Assessment1366-52782046-49242015-01-0119510.3310/hta1905007/43/01The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary careJackie A Cassell0Julie Dodds1Claudia Estcourt2Carrie Llewellyn3Stefania Lanza4John Richens5Helen Smith6Merle Symonds7Andrew Copas8Tracy Roberts9Kate Walters10Peter White11Catherine Lowndes12Hema Mistry13Melcior Rossello-Roig14Hilary Smith15Greta Rait16Division of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton, UKMedical Research Council, General Practice Research Framework, London, UKBICMS, Barts and The London School of Medicine and Dentistry, Queen Mary College, University of London, London, UKDivision of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton, UKDivision of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton, UKResearch Department of Primary Care and Population Health, UCL and Medical Research Council General Practice Research Framework, London, UKDivision of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton, UKBICMS, Barts and The London School of Medicine and Dentistry, Queen Mary College, University of London, London, UKResearch Department of Primary Care and Population Health, UCL and Medical Research Council General Practice Research Framework, London, UKHealth Economics Unit, School of Health and Population Science, University of Birmingham, UKResearch Department of Primary Care and Population Health, UCL and Medical Research Council General Practice Research Framework, London, UKMRC Centre for Outbreak Analysis and Modelling and NIHR Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UKSTI Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UKHealth Economics Unit, School of Health and Population Science, University of Birmingham, UKHealth Economics Unit, School of Health and Population Science, University of Birmingham, UKDivision of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton, UKMedical Research Council, General Practice Research Framework, London, UKBackground: Partner notification is the process of providing support for, informing and treating sexual partners of individuals who have been diagnosed with sexually transmitted infections (STIs). It is traditionally undertaken by specialist sexual health services, and may involve informing a partner on a patient’s behalf, with consent. With an increasing proportion of STIs diagnosed in general practice and other community settings, there is a growing need to understand the best way to provide partner notification for people diagnosed with a STI in this setting using a web-based referral system. Objective: We aimed to compare three different approaches to partner notification for people diagnosed with chlamydia within general practice. Design: Cluster randomised controlled trial. Setting: General practices in England and, within these, patients tested for and diagnosed with genital chlamydia or other bacterial STIs in that setting using a web-based referral system. Interventions: Three different approaches to partner notification: patient referral alone, or the additional offer of either provider referral or contract referral. Main outcome measures: (1) Number of main partners per index patient treated for chlamydia and/or gonorrhoea/non-specific urethritis/pelvic inflammatory disease; and (2) proportion of index patients testing negative for the relevant STI at 3 months. Results: As testing rates for chlamydia were far lower than expected, we were unable to scale up the trial, which was concluded at pilot stage. We are not able to answer the original research question. We present the results of the work undertaken to improve recruitment to similar studies requiring opportunistic recruitment of young people in general practice. We were unable to standardise provider and contract referral separately; however, we also present results of qualitative work aimed at optimising these interventions. Conclusions: External recruitment may be required to facilitate the recruitment of young people to research in general practice, especially in sensitive areas, because of specific barriers experienced by general practice staff. Costs need to be taken into account together with feasibility considerations. Partner notification interventions for bacterial STIs may not be clearly separable into the three categories of patient, provider and contract referral. Future research is needed to operationalise the approaches of provider and contract partner notification if future trials are to provide generalisable information. Trial registration: Current Controlled Trials ISRCTN24160819. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 5. See the NIHR Journals Library website for further project information.https://doi.org/10.3310/hta19050